Mer­ck, Pfiz­er end patent feud over pneu­mo­coc­cal vac­cines with roy­al­ty-cen­tered set­tle­ment

A long-run­ning patent bat­tle be­tween two phar­ma gi­ants over their com­pet­ing pneu­mo­coc­cal con­ju­gate vac­cines has come to an end.

Mer­ck and Pfiz­er have reached a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER